New recommendations for ASA in prevention of cardiovascular disease
CSHP has been invited to endorse draft recommendations on the use of ASA for the prevention of cardiovascular disease.
In collaboration with the Heart & Stroke Foundation, CSHP members Bill Semchuk and Christine Papoushek were part of the group that developed these recommendations, which have been submitted to CMAJ for publication.
We have the opportunity to endorse the draft recommendations and would like to convene a small working group of CSHP members to review and provide a recommendation on endorsement.
If you are interested in being part of this small working group, please email Chief Pharmacy Officer Christina Adams, firstname.lastname@example.org, by Friday, December 20th with a letter of intent outlining why you’d like to be a part of the working group and your expertise in the area.